{"id":"https://openalex.org/W4361894480","doi":"https://doi.org/10.1158/0008-5472.22385880","title":"Supplementary Methods, Figure Legends 1-7 from FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer","display_name":"Supplementary Methods, Figure Legends 1-7 from FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361894480","doi":"https://doi.org/10.1158/0008-5472.22385880"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22385880","doi":"https://doi.org/10.1158/0008-5472.22385880","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22385880","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_1-7_from_i_FGFR1_i_Amplification_Drives_Endocrine_Therapy_Resistance_and_Is_a_Therapeutic_Target_in_Breast_Cancer/22385880/1/files/39831333.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_1-7_from_i_FGFR1_i_Amplification_Drives_Endocrine_Therapy_Resistance_and_Is_a_Therapeutic_Target_in_Breast_Cancer/22385880/1/files/39831333.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060044961","display_name":"Nicholas C. Turner","orcid":"https://orcid.org/0000-0001-8937-0873","observed_orcids":["https://orcid.org/0000-0001-8937-0873"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas Turner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031626209","display_name":"Alexander T. Pearson","orcid":"https://orcid.org/0000-0003-2801-7456","observed_orcids":["https://orcid.org/0000-0003-2801-7456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Pearson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086474840","display_name":"Rachel Sharpe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Sharpe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111839800","display_name":"Maryou B.K. Lambros","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maryou Lambros","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103035323","display_name":"Felipe Correa Geyer","orcid":"https://orcid.org/0000-0002-9978-6650","observed_orcids":["https://orcid.org/0000-0002-9978-6650","https://orcid.org/0000-0002-9625-2346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felipe Geyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111669412","display_name":"Mar\u00eda \u00c1ngeles L\u00f3pez\u2010Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria A. Lopez-Garcia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057324933","display_name":"Rachael Natrajan","orcid":"https://orcid.org/0000-0002-9987-2946","observed_orcids":["https://orcid.org/0000-0002-9987-2946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachael Natrajan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065261887","display_name":"Caterina Marchi\u00f2","orcid":"https://orcid.org/0000-0003-2024-6131","observed_orcids":["https://orcid.org/0000-0003-2024-6131"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caterina Marchio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040386046","display_name":"Elizabeth J. Iorns","orcid":"https://orcid.org/0000-0002-5515-1258","observed_orcids":["https://orcid.org/0000-0002-5515-1258"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Iorns","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073016473","display_name":"Alan G. Mackay","orcid":"https://orcid.org/0000-0003-3323-4017","observed_orcids":["https://orcid.org/0000-0003-3323-4017"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Mackay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055450638","display_name":"Cheryl Gillett","orcid":"https://orcid.org/0000-0003-3643-4057","observed_orcids":["https://orcid.org/0000-0003-3643-4057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheryl Gillett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054103832","display_name":"Anita E. Grigoriadis","orcid":"https://orcid.org/0000-0003-3434-201X","observed_orcids":["https://orcid.org/0000-0003-3434-201X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anita Grigoriadis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087121536","display_name":"Andrew N.J. Tutt","orcid":"https://orcid.org/0000-0001-8715-2901","observed_orcids":["https://orcid.org/0000-0001-8715-2901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Tutt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077235697","display_name":"Jorge Sergio Reis-Filho","orcid":"https://orcid.org/0000-0003-2969-3173","observed_orcids":["https://orcid.org/0000-0003-2969-3173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge S. Reis-Filho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058973407","display_name":"Alan Ashworth","orcid":"https://orcid.org/0000-0003-1446-7878","observed_orcids":["https://orcid.org/0000-0003-1446-7878","https://orcid.org/0009-0008-8974-2233"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Ashworth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.41359999775886536,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.41359999775886536,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.2533999979496002,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.1306000053882599,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgfr1-amplification","display_name":"FGFR1 amplification","score":0.9079999923706055},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.8709999918937683},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.777999997138977},{"id":"https://openalex.org/keywords/fgfr1","display_name":"FGFR1","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.6297016739845276},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5776317119598389},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4780353009700775},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4405369460582733},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4370250999927521},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43345001339912415},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4275239109992981},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.1321100890636444}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22385880","doi":"https://doi.org/10.1158/0008-5472.22385880","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22385880","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_1-7_from_i_FGFR1_i_Amplification_Drives_Endocrine_Therapy_Resistance_and_Is_a_Therapeutic_Target_in_Breast_Cancer/22385880/1/files/39831333.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22385880.v1","doi":"https://doi.org/10.1158/0008-5472.22385880.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22385880.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22385880","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_1-7_from_i_FGFR1_i_Amplification_Drives_Endocrine_Therapy_Resistance_and_Is_a_Therapeutic_Target_in_Breast_Cancer/22385880","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22385880","doi":"https://doi.org/10.1158/0008-5472.22385880","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22385880","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_1-7_from_i_FGFR1_i_Amplification_Drives_Endocrine_Therapy_Resistance_and_Is_a_Therapeutic_Target_in_Breast_Cancer/22385880/1/files/39831333.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361894480.pdf","grobid_xml":"https://content.openalex.org/works/W4361894480.grobid-xml"},"referenced_works_count":8,"referenced_works":["https://openalex.org/W1546709038","https://openalex.org/W1563198888","https://openalex.org/W2076356585","https://openalex.org/W2118155696","https://openalex.org/W2139889421","https://openalex.org/W2160450758","https://openalex.org/W2170278022","https://openalex.org/W7074103484"],"related_works":["https://openalex.org/W2101844536","https://openalex.org/W4392679251","https://openalex.org/W2965244954","https://openalex.org/W2626291857","https://openalex.org/W4361953205","https://openalex.org/W1470971752","https://openalex.org/W6920887461","https://openalex.org/W6958522247","https://openalex.org/W6920713639","https://openalex.org/W6920799303"],"abstract_inverted_index":{"Supplementary":[0],"Methods,":[1],"Figure":[2],"Legends":[3],"1-7":[4],"from":[5],"FGFR1":[6],"Amplification":[7],"Drives":[8],"Endocrine":[9],"Therapy":[10],"Resistance":[11],"and":[12],"Is":[13],"a":[14],"Therapeutic":[15],"Target":[16],"in":[17],"Breast":[18],"Cancer":[19]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}